Cerus Corp. Company Profile (NASDAQ:CERS)

About Cerus Corp.

Cerus Corp. logoCerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: CERS
  • CUSIP: 15708510
Key Metrics:
  • Previous Close: $6.23
  • 50 Day Moving Average: $6.50
  • 200 Day Moving Average: $6.21
  • 52-Week Range: $4.27 - $7.64
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.68
  • P/E Growth: 0.00
  • Market Cap: $647.07M
  • Outstanding Shares: 102,709,000
  • Beta: 1.78
Profitability:
  • Net Margins: -189.29%
  • Return on Equity: -73.14%
  • Return on Assets: -48.73%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 4.36%
  • Quick Ratio: 3.89%
Additional Links:
Companies Related to Cerus Corp.:

Analyst Ratings

Consensus Ratings for Cerus Corp. (NASDAQ:CERS) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $9.10 (44.44% upside)

Analysts' Ratings History for Cerus Corp. (NASDAQ:CERS)
Show:
DateFirmActionRatingPrice TargetDetails
9/7/2016FBR & CoReiterated RatingOutperform$10.00View Rating Details
8/6/2016Robert W. BairdSet Price TargetBuy$9.00 -> $10.00View Rating Details
7/31/2016Cantor FitzgeraldReiterated RatingBuy$9.00View Rating Details
6/20/2016BTIG ResearchReiterated RatingBuy$10.00View Rating Details
2/6/2016StephensReiterated RatingBuyView Rating Details
1/29/2016Cowen and CompanyReiterated RatingBuyView Rating Details
12/17/2015WedbushDowngradeOutperform -> Neutral$6.50View Rating Details
6/30/2015MLV & Co.Reiterated RatingBuy$10.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Cerus Corp. (NASDAQ:CERS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.17)($0.18)$8.88 million$9.25 millionViewN/AView Earnings Details
5/3/2016Q1($0.16)($0.17)$8.29 million$7.60 millionViewN/AView Earnings Details
3/8/2016Q415($0.16)($0.15)$9.72 million$9.70 millionViewListenView Earnings Details
11/5/2015Q315($0.16)($0.17)$10.00 million$8.04 millionViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.17)$8.71 million$8.83 millionViewN/AView Earnings Details
5/5/2015Q214($0.16)($0.17)$7.70 million$7.70 millionViewN/AView Earnings Details
2/26/2015Q114($0.15)($0.25)$10.36 million$9.70 millionViewN/AView Earnings Details
11/4/2014Q413($0.13)($0.15)$9.83 million$10.36 millionViewN/AView Earnings Details
7/31/2014Q313($0.13)($0.16)$8.17 million$8.60 millionViewN/AView Earnings Details
5/1/2014Q313($0.12)($0.12)$9.65 million$7.86 millionViewN/AView Earnings Details
2/25/2014Q213($0.09)($0.10)$11.77 million$9.23 millionViewN/AView Earnings Details
10/29/2013($0.09)($0.29)$10.34 million$10.54 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cerus Corp. (NASDAQ:CERS)
Current Year EPS Consensus Estimate: $-0.67 EPS
Next Year EPS Consensus Estimate: $-0.59 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.16)($0.16)($0.16)
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cerus Corp. (NASDAQ:CERS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cerus Corp. (NASDAQ:CERS)
Insider Ownership Percentage: 6.60%
Institutional Ownership Percentage: 67.01%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2016Kevin Dennis GreenCFOSell17,150$6.80$116,620.00View SEC Filing  
8/19/2015Laurence M CorashInsiderBuy25,900$4.99$129,241.00View SEC Filing  
8/18/2015Laurence M CorashInsiderBuy84,600$4.77$403,542.00View SEC Filing  
11/10/2014William Mariner GreenmanCEOBuy21,800$3.93$85,674.00View SEC Filing  
11/19/2012William Mariner GreenmanCEOBuy3,200$3.02$9,664.00View SEC Filing  
11/16/2012Laurence M CorashInsiderBuy2,000$2.85$5,700.00View SEC Filing  
11/16/2012William Mariner GreenmanCEOBuy13,800$2.85$39,330.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cerus Corp. (NASDAQ:CERS)
DateHeadline
News IconFirst Week of May 2017 Options Trading For Cerus (CERS) (NASDAQ:CERS)
www.stockoptionschannel.com - September 22 at 4:21 PM
News IconMover To Watch: Cerus Corporation (NASDAQ:CERS) , Destination ... - Wall Street Times (press release) (NASDAQ:CERS)
www.wallstreetnews24.com - September 21 at 4:48 PM
News IconIntraday Active Biotech Stocks News: Cerus Corporation (NASDAQ:CERS), INSYS Therapeutics, Inc. (NASDAQ:INSY) - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - September 15 at 4:31 PM
bizjournals.com logoHow this East Bay company is helping squash Zika (NASDAQ:CERS)
www.bizjournals.com - September 13 at 8:59 AM
News IconHot Biotech Stocks Recap: Geron Corporation (NASDAQ:GERN), Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - September 12 at 4:01 PM
News IconBiotech news that matter for investors: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - September 9 at 8:59 AM
News IconPlacing Cerus Corporation (NASDAQ:CERS) Shares Under the Microscope - Post News (NASDAQ:CERS)
www.kentuckypostnews.com - September 8 at 5:52 AM
publicnow.com logoCerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:CERS)
www.publicnow.com - September 7 at 9:20 AM
News IconCerus Corporation (NASDAQ:CERS) Analyst Estimates - The Independent Republic (NASDAQ:CERS)
theindependentrepublic.com - September 2 at 3:58 PM
biz.yahoo.com logoCERUS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:CERS)
biz.yahoo.com - September 1 at 12:38 PM
capitalcube.com logoCerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : September 1, 2016 (NASDAQ:CERS)
www.capitalcube.com - September 1 at 12:38 PM
finance.yahoo.com logoCerus to Present at the Baird 2016 Healthcare Conference on September 8, 2016 (NASDAQ:CERS)
finance.yahoo.com - September 1 at 12:38 PM
huffingtonpost.com logoFDA To Screen All Donated Blood For The Zika Virus (NASDAQ:CERS)
www.huffingtonpost.com - August 30 at 12:04 PM
streetinsider.com logoCerus (CERS) Affirms Revised FDA Guidance with Respect to Zika Virus Testing (NASDAQ:CERS)
www.streetinsider.com - August 30 at 12:04 PM
News IconFDA's New Recommendation for Universal Zika Risk Reduction of Blood Components Includes Use of Pathogen Reduction (NASDAQ:CERS)
www.pharmiweb.com - August 30 at 12:04 PM
benzinga.com logoCerus INTERCEPT Blood System Among New Safety Measures Recommended By FDA - Benzinga (NASDAQ:CERS)
www.benzinga.com - August 29 at 3:32 PM
News IconThe Key Numbers To Watch From Cerus Corporation (NASDAQ:CERS)'s Earnings - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - August 29 at 3:32 PM
News IconBiotech Stocks To Put On Your Watch List: Cerus Corporation (NASDAQ:CERS), Array BioPharma Inc. (NASDAQ:ARRY) - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - August 29 at 3:32 PM
feeds.benzinga.com logoCerus INTERCEPT Blood System Among New Safety Measures Recommended By FDA (NASDAQ:CERS)
feeds.benzinga.com - August 29 at 12:41 PM
4-traders.com logoCerus : FDA's New Recommendation for Universal Zika Risk Reduction of Blood Components Includes Use of Pathogen Reduction (NASDAQ:CERS)
www.4-traders.com - August 29 at 8:54 AM
reuters.com logoFDA recommends Zika testing for all blood donated in U.S. (NASDAQ:CERS)
www.reuters.com - August 28 at 8:51 AM
News IconRecent Insider Activity: Cerus Corporation (NASDAQ:CERS) - Post Registrar (NASDAQ:CERS)
postregistrar.com - August 27 at 9:11 AM
finance.yahoo.com logoUPDATE 4-FDA recommends Zika testing for all blood donated in U.S. (NASDAQ:CERS)
finance.yahoo.com - August 27 at 9:11 AM
capitalcube.com logoETF’s with exposure to Cerus Corp. : August 26, 2016 (NASDAQ:CERS)
www.capitalcube.com - August 26 at 11:59 AM
finance.yahoo.com logoCERUS CORP Financials (NASDAQ:CERS)
finance.yahoo.com - August 16 at 4:12 PM
capitalcube.com logoETF’s with exposure to Cerus Corp. : August 11, 2016 (NASDAQ:CERS)
www.capitalcube.com - August 11 at 4:14 PM
investopedia.com logoBuy the Dip During Dog Days (AKS, CERS) (NASDAQ:CERS)
www.investopedia.com - August 10 at 4:12 PM
capitalcube.com logoCerus Corp. :CERS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:CERS)
www.capitalcube.com - August 10 at 4:12 PM
equities.com logoCerus Corporation (CERS) Drops 5.75% on August 08 - Equities.com (NASDAQ:CERS)
www.equities.com - August 9 at 9:56 PM
twst.com logoCerus Corporation: Vivek Jayaraman Appointed as Cerus Corporation’s Chief Commercial Officer (NASDAQ:CERS)
www.twst.com - August 9 at 12:23 PM
News IconVivek JayaramanAppointed as Cerus Corporations Chief Commercial Officer (NASDAQ:CERS)
www.cbs58.com - August 9 at 12:23 PM
publicnow.com logoVivek Jayaraman Appointed as Cerus Corporation’s Chief Commercial Officer (NASDAQ:CERS)
www.publicnow.com - August 9 at 12:23 PM
finance.yahoo.com logoEdited Transcript of CERS earnings conference call or presentation 4-Aug-16 8:15pm GMT (NASDAQ:CERS)
finance.yahoo.com - August 8 at 8:58 AM
fortune.com logoThese Are Analyst Ratings Worth Watching: Cerus Corporation (NASDAQ:CERS), TherapeuticsMD Inc (NYSEMKT ... - Review Fortune (NASDAQ:CERS)
reviewfortune.com - August 6 at 11:47 AM
benzinga.com logoZika Headlines Continue To Be Tailwinds For Cerus (NASDAQ:CERS)
www.benzinga.com - August 5 at 4:11 PM
biz.yahoo.com logoCERUS CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:CERS)
biz.yahoo.com - August 5 at 4:11 PM
sg.finance.yahoo.com logoCerus reports 2Q loss (NASDAQ:CERS)
sg.finance.yahoo.com - August 4 at 9:52 PM
finance.yahoo.com logoCerus Corporation Reports Second Quarter 2016 Results (NASDAQ:CERS)
finance.yahoo.com - August 4 at 4:18 PM
equities.com logoCerus Corporation (CERS) Hits New 52-week High During August 01 Session - Equities.com (NASDAQ:CERS)
www.equities.com - August 3 at 12:27 PM
News IconBiotechnology Stocks Under Review: Cerus Corporation (NASDAQ:CERS), Inovio Pharmaceuticals Inc (NASDAQ:INO) - Post Registrar (NASDAQ:CERS)
postregistrar.com - August 2 at 4:15 PM
News IconAnalyst's Report Preview: Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - August 2 at 8:56 AM
News IconHC Stocks Analysis: Cerus Corporation (NASDAQ:CERS) Anavex Life Sciences Corp. (NASDAQ:AVXL) - share market updates (press release) (NASDAQ:CERS)
sharemarketupdates.com - August 1 at 8:59 AM
finance.yahoo.com logoCerus (CERS) in Focus: Stock Moves 6% Higher in Session (NASDAQ:CERS)
finance.yahoo.com - August 1 at 8:05 AM
News IconIt's Earnings Time: What to Do with Cerus Corporation (NASDAQ ... - The Voice Registrar (NASDAQ:CERS)
voiceregistrar.com - July 30 at 12:40 PM
equities.com logoCerus Corporation (CERS) is Trading Higher on Unusual Volume for July 28 - Equities.com (NASDAQ:CERS)
www.equities.com - July 30 at 12:40 PM
equities.com logoCerus Corporation (CERS) Jumps 6.03% on July 29 - Equities.com (NASDAQ:CERS)
www.equities.com - July 30 at 12:40 PM
smarteranalyst.com logoCantor Weighs In on Cerus Corporation (CERS) as FDA Halted Blood Donations in Two FL Counties Due to Zika - Smarter Analyst (NASDAQ:CERS)
www.smarteranalyst.com - July 29 at 9:37 PM
streetupdates.com logoAnalysts Update on Stocks: Pfizer, Inc. (NYSE:PFE) , Cerus Corporation (NASDAQ:CERS) - Street Updates (NASDAQ:CERS)
www.streetupdates.com - July 29 at 4:15 PM
News IconInvestor Catching Stock: Cerus Corporation (NASDAQ:CERS) - News Oracle (NASDAQ:CERS)
www.newsoracle.com - July 29 at 4:14 PM
finance.yahoo.com logoFriday's Zika Reports Explained: Winners And Losers (NASDAQ:CERS)
finance.yahoo.com - July 29 at 2:46 PM

Social

Cerus Corp. (NASDAQ:CERS) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff